Innovation in Ireland →
Managing director, the Foundry Group
VP of Research and Special Initiatives, Google
Co-Founder, VP of Technology, Entropic Communications
VP of Research & Policy, Ewing Marion Kauffman Foundation
Professor of Systems Biology, Columbia University
Avila Therapeutics develops drugs to silence disease proteins through covalent bonding with targets.
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin and beyond.
© 2007-2015, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.